Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ab-729 (1 trial)
ati-2173 (6 trials)
tenofovir (viread) (3 trials)
vebicorvir (1 trial)
clarithromycin (biaxin) (1 trial)
midazolam (versed) (1 trial)
Hepatitis (Phase 1)
Hepatitis A (Phase 1)
Hepatitis B (Phase 1)
Hepatitis B, Chronic (Phase 1)
Herpesviridae Infections (Phase 1)
Virus Diseases (Phase 1)
Trials (6 total)
Trial APIs (6 total)